Suppression of pro-fibrotic signaling potentiates factor-mediated reprogramming of mouse embryonic fibroblasts into induced cardiomyocytes

Andrew S. Riching, Yuanbiao Zhao, Yingqiong Cao, Pilar Londono, Hongyan Xu, Kunhua Song

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Trans-differentiation of one somatic cell type into another has enormous potential to model and treat human diseases. Previous studies have shown that mouse embryonic, dermal, and cardiac fibroblasts can be reprogrammed into functional induced-cardiomyocyte-like cells (iCMs) through overexpression of cardiogenic transcription factors including GATA4, Hand2, Mef2c, and Tbx5 both in vitro and in vivo. However, these previous studies have shown relatively low efficiency. In order to restore heart function following injury, mechanisms governing cardiac reprogramming must be elucidated to increase efficiency and maturation of iCMs. We previously demonstrated that inhibition of pro-fibrotic signaling dramatically increases reprogramming efficiency. Here, we detail methods to achieve a reprogramming efficiency of up to 60%. Furthermore, we describe several methods including flow cytometry, immunofluorescent imaging, and calcium imaging to quantify reprogramming efficiency and maturation of reprogrammed fibroblasts. Using the protocol detailed here, mechanistic studies can be undertaken to determine positive and negative regulators of cardiac reprogramming. These studies may identify signaling pathways that can be targeted to promote reprogramming efficiency and maturation, which could lead to novel cell therapies to treat human heart disease.

Original languageEnglish (US)
Article numbere57687
JournalJournal of Visualized Experiments
Volume2018
Issue number136
DOIs
StatePublished - Jun 3 2018

Fingerprint

Fibroblasts
Cardiac Myocytes
GATA4 Transcription Factor
Cell- and Tissue-Based Therapy
Heart Diseases
Flow Cytometry
Calcium
Skin
Wounds and Injuries
Imaging techniques
Transcription factors
Flow cytometry
Transcription Factors
Cells
In Vitro Techniques

Keywords

  • Cardiac reprogramming
  • Compound
  • Developmental Biology
  • Issue 136
  • MicroRNAs
  • Pro-fibrotic signaling
  • TGF-β receptor 1 inhibitor
  • Transcription factors

ASJC Scopus subject areas

  • Neuroscience(all)
  • Chemical Engineering(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Suppression of pro-fibrotic signaling potentiates factor-mediated reprogramming of mouse embryonic fibroblasts into induced cardiomyocytes. / Riching, Andrew S.; Zhao, Yuanbiao; Cao, Yingqiong; Londono, Pilar; Xu, Hongyan; Song, Kunhua.

In: Journal of Visualized Experiments, Vol. 2018, No. 136, e57687, 03.06.2018.

Research output: Contribution to journalArticle

@article{8323267e97814f758e2c8ffa44ef0265,
title = "Suppression of pro-fibrotic signaling potentiates factor-mediated reprogramming of mouse embryonic fibroblasts into induced cardiomyocytes",
abstract = "Trans-differentiation of one somatic cell type into another has enormous potential to model and treat human diseases. Previous studies have shown that mouse embryonic, dermal, and cardiac fibroblasts can be reprogrammed into functional induced-cardiomyocyte-like cells (iCMs) through overexpression of cardiogenic transcription factors including GATA4, Hand2, Mef2c, and Tbx5 both in vitro and in vivo. However, these previous studies have shown relatively low efficiency. In order to restore heart function following injury, mechanisms governing cardiac reprogramming must be elucidated to increase efficiency and maturation of iCMs. We previously demonstrated that inhibition of pro-fibrotic signaling dramatically increases reprogramming efficiency. Here, we detail methods to achieve a reprogramming efficiency of up to 60{\%}. Furthermore, we describe several methods including flow cytometry, immunofluorescent imaging, and calcium imaging to quantify reprogramming efficiency and maturation of reprogrammed fibroblasts. Using the protocol detailed here, mechanistic studies can be undertaken to determine positive and negative regulators of cardiac reprogramming. These studies may identify signaling pathways that can be targeted to promote reprogramming efficiency and maturation, which could lead to novel cell therapies to treat human heart disease.",
keywords = "Cardiac reprogramming, Compound, Developmental Biology, Issue 136, MicroRNAs, Pro-fibrotic signaling, TGF-β receptor 1 inhibitor, Transcription factors",
author = "Riching, {Andrew S.} and Yuanbiao Zhao and Yingqiong Cao and Pilar Londono and Hongyan Xu and Kunhua Song",
year = "2018",
month = "6",
day = "3",
doi = "10.3791/57687",
language = "English (US)",
volume = "2018",
journal = "Journal of visualized experiments : JoVE",
issn = "1940-087X",
publisher = "MYJoVE Corporation",
number = "136",

}

TY - JOUR

T1 - Suppression of pro-fibrotic signaling potentiates factor-mediated reprogramming of mouse embryonic fibroblasts into induced cardiomyocytes

AU - Riching, Andrew S.

AU - Zhao, Yuanbiao

AU - Cao, Yingqiong

AU - Londono, Pilar

AU - Xu, Hongyan

AU - Song, Kunhua

PY - 2018/6/3

Y1 - 2018/6/3

N2 - Trans-differentiation of one somatic cell type into another has enormous potential to model and treat human diseases. Previous studies have shown that mouse embryonic, dermal, and cardiac fibroblasts can be reprogrammed into functional induced-cardiomyocyte-like cells (iCMs) through overexpression of cardiogenic transcription factors including GATA4, Hand2, Mef2c, and Tbx5 both in vitro and in vivo. However, these previous studies have shown relatively low efficiency. In order to restore heart function following injury, mechanisms governing cardiac reprogramming must be elucidated to increase efficiency and maturation of iCMs. We previously demonstrated that inhibition of pro-fibrotic signaling dramatically increases reprogramming efficiency. Here, we detail methods to achieve a reprogramming efficiency of up to 60%. Furthermore, we describe several methods including flow cytometry, immunofluorescent imaging, and calcium imaging to quantify reprogramming efficiency and maturation of reprogrammed fibroblasts. Using the protocol detailed here, mechanistic studies can be undertaken to determine positive and negative regulators of cardiac reprogramming. These studies may identify signaling pathways that can be targeted to promote reprogramming efficiency and maturation, which could lead to novel cell therapies to treat human heart disease.

AB - Trans-differentiation of one somatic cell type into another has enormous potential to model and treat human diseases. Previous studies have shown that mouse embryonic, dermal, and cardiac fibroblasts can be reprogrammed into functional induced-cardiomyocyte-like cells (iCMs) through overexpression of cardiogenic transcription factors including GATA4, Hand2, Mef2c, and Tbx5 both in vitro and in vivo. However, these previous studies have shown relatively low efficiency. In order to restore heart function following injury, mechanisms governing cardiac reprogramming must be elucidated to increase efficiency and maturation of iCMs. We previously demonstrated that inhibition of pro-fibrotic signaling dramatically increases reprogramming efficiency. Here, we detail methods to achieve a reprogramming efficiency of up to 60%. Furthermore, we describe several methods including flow cytometry, immunofluorescent imaging, and calcium imaging to quantify reprogramming efficiency and maturation of reprogrammed fibroblasts. Using the protocol detailed here, mechanistic studies can be undertaken to determine positive and negative regulators of cardiac reprogramming. These studies may identify signaling pathways that can be targeted to promote reprogramming efficiency and maturation, which could lead to novel cell therapies to treat human heart disease.

KW - Cardiac reprogramming

KW - Compound

KW - Developmental Biology

KW - Issue 136

KW - MicroRNAs

KW - Pro-fibrotic signaling

KW - TGF-β receptor 1 inhibitor

KW - Transcription factors

UR - http://www.scopus.com/inward/record.url?scp=85049840658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049840658&partnerID=8YFLogxK

U2 - 10.3791/57687

DO - 10.3791/57687

M3 - Article

C2 - 29912202

AN - SCOPUS:85049840658

VL - 2018

JO - Journal of visualized experiments : JoVE

JF - Journal of visualized experiments : JoVE

SN - 1940-087X

IS - 136

M1 - e57687

ER -